BRAF mutations in colorectal cancer patients with liver metastases are linked to poorer survival outcomes. However, liver resection shows a significant 56% reduction in the risk of death for patients with BRAF-mutated colorectal liver metastases. Surgical intervention offers a clear survival benefit, with a reduced hazard ratio of 0.44 favoring surgery.
Review by Petrelli F, Arru M (…) Sozzi A et 11 al. in Eur J Surg Oncol
© 2024 Published by Elsevier Ltd.
Summaries are written to help you decide what to read. They do not replace the full paper.
Free · 5 minutes a day
Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.
More in HPB & Spleen
Patients with better blood nutrition scores lived longer after surgery for gallbladder cancer, in a study of 1,312 patients.
Drugs given around liver cancer surgery have mostly failed, but one recent trial showed a real benefit.
In two older patients having robotic surgery for a pancreatic growth, ductoscopy and checks of the cut edge let surgeons leave the remaining pancreas in place.
